Company Performance Metrics
- Shi Junliang: Chairman
- Shi Junliang: Chairman
Chuangyi Biotech focuses on self-funded drugs and health foods in the R&D/marketing quality improvement category (QOL). For the current health care resources in Taiwan, which tend to be more serious in cancer/anti-infection, the health insurance policy will gradually not pay for non-critical diseases. The concept of drug expenses for
patients with non-significant diseases is increasing, and the concept of preventive medical care has increased year by year. The demand for self-funded drugs and healthy foods in the quality of life improvement category (QOL) is growing (Ex. Obesity, diabetes prevention, Sexual dysfunction, anti-aging, allergic and immune diseases, intestinal health care, in summary, Chuangyi Biotechnology adheres to the spirit of empirical medicine, providing high-quality/high-efficiency and innovative self-funded medicines and healthy foods for Chinese people, which can satisfy the health of Chinese people. Health needs and improve the quality of life of Chinese people.
